SlideShare uma empresa Scribd logo
1 de 77
Diane Gulczynski, RN, MS, CNOR Senior Vice President, Patient Care Services Maureen Spencer, RN,M.Ed., CIC Infection Control Manager New England Baptist Hospital, Boston, Ma.
New England Baptist Hospital ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Massachusetts Health  Data Consortium ,[object Object],[object Object],[object Object]
New England Baptist Hospital    Orthopaedic Surgery – 2007 Massachusetts Market
The inpatient orthopedic surgical market is growing and will continue – due to 1 : ,[object Object],[object Object],[object Object],[object Object],1. Herndon JH. The future of orthopaedics.  AAOS Bulletin (online). June 2004; 52:3.  Available at  http://www.aaos.org/wordhtml/bulletin/jun04/fline3.htm . Accessed May 16, 2006.
Orthopedic Surgical Site Infection ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Staphylococcus Aureus Methicillin Sensitive (MSSA) ,[object Object],[object Object],[object Object],[object Object],[object Object]
Methicillin-resistant  Staphylococcus Aureus (MRSA)
MRSA ,[object Object],[object Object],[object Object],[object Object]
Reason #1:     Increase in MRSA in Community ,[object Object],Why NEBH Implemented  An Eradication Program
Reason #2  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Staph aureus and MRSA Secondary Bacteremias Associated with Surgical Site Infections
? Point Source Outbreak ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Program Implementation ,[object Object],[object Object],[object Object],[object Object],[object Object]
Senior VP Patient Care Services ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
February 2006  Anonymous Nares Cultures ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Board Approved Implementation Task Force Established March 2006 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Screening Proposals ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Estimated Cost of the MRSA/MSSA Program ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MRSA Reimbursement Code CPT Code Charge 87081  Rule Out Cx   $28.00  87641 MRSA by PCR  $110.00  as of 4/30/09 BC Indemnity  $76.13  Tufts  $62.39  Blue Care Elect  $55.42  HMO Blue  $53.20  HPHC  $49.49  Medicare  $38.03  Medicaid  $27.17  United Healthcare $82.01
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Implementation Steps
Policy and Procedure ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Implementation Steps ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pre-admission Testing ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Teamwork ,[object Object],[object Object],[object Object],[object Object],[object Object]
MRSA Eradication Program and Results Maureen Spencer,RN
History of MRSA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Linezolid (Zyvox) ,[object Object],[object Object],[object Object]
Daptomycin (Cubicin) ,[object Object],[object Object],[object Object]
Vancomycin Resistance ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Minimum Inhibitory Concentration (MIC) Creep ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MIC Creep ,[object Object],[object Object]
How Does it Get Resistant? ,[object Object],[object Object],[object Object],[object Object]
Penicillin-Binding Protein (PBP) 2a ,[object Object],[object Object],[object Object]
Severe cases of Community Acquired-MRSA ,[object Object],[object Object],[object Object],[object Object]
Phenol-Soluble Modulin Proteins ,[object Object],[object Object],[object Object],[object Object],[object Object]
Differences in Strains ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
MRSA COLONIZATION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
SURGICAL SITE INFECTIONS
Surgical Site Infection ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[Whitehouse et al, Infect Control Hosp Epidemiol 2002]
Risk of SSI Increased in Nasal Carriers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Risk Factors for S. Aureus  SSI ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[Munoz et al, J Hosp Infect 2008]
Risk of MRSA Nasal Carriage ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[Morange-Saussier et al, Ann Vasc Surg 2006]
Environmental Reservoirs ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[Sexton et al, J Hosp Infect 2006]
Environmental Reservoirs [Sexton et al, J Hosp Infect 2006]
Potential Airborne Transmission [Sexton et al, J Hosp Infect 2006]
Airborne Transmission ,[object Object],[object Object],[object Object],[Shiomori et al, J Hosp Infect 2002]
Inadequate Patient Space ,[object Object],[object Object],[object Object],[Kibbler et al, J Hosp Infect 1998]
Long-term Care Facilities ,[object Object],[Asoh et al, Intern Med 2005]
Decolonization of Carriers ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Mupirocin and the Risk of  S.Aureus  (MARS) Study ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[Perl et al, N Engl J Med 2002]
MARS Study Analysis ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[Perl et al, N Engl J Med 2002]
MARS Study Infection Rates ,[object Object],[object Object],[object Object],[object Object],[object Object]
Preoperative Decolonization ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[Rao et al, Clin Orthop Relat Res 2008]
Pittsburgh Protocol ,[object Object],[object Object],[object Object],[object Object],[Rao et al, Clin Orthop Relat Res 2008]
Pittsburgh Results [Rao et al, Clin Orthop Relat Res 2008]
Pittsburgh Results ,[object Object],[object Object],[Rao et al, Clin Orthop Relat Res 2008]
Cost-effectiveness Analyses ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[Young and Winston, Infect Control Hosp Epidemiol 2006]
Nationwide Cost-effectiveness ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[ Noskin et al, Infect Control Hosp Epidemiol 2008]
Potential Cost Savings NEBH ,[object Object],[object Object]
Intangible Benefits ,[object Object],[object Object]
Concerns
Our Experience and Evidence Surveillance Data JBJS
MRSA/MSSA Eradication Results ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],% MRSA and  Staph aureus  SSI
0 . 18 % 0 . 06 % 0.26% 0.13 % Pre (2006) and Post (2007) 50% Reduction in Staph aureus SSI   60% Reduction in MRSA SSI   MRSA SSI Rate MSSA SSI Rate 10/01/05-07/16/06 07/17/06-09/30/07 10/01/05-07/16/06 07/17/06-09/30/07
Surgical Site Infections ,[object Object],[object Object],[object Object],[object Object],0.21% 1.16%
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],% MRSA SSI in  MRSA +  Screened Patients
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],%  Staph aureus (MSSA)  SSI in  Screen + Patients
Issues Identified Per Fiscal Year ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],FY2003 FY2004 FY2005 FY2006 FY2008 FY2009
OR Cleanup Bundle Approach to Reducing SSI
Orthopedic Surgical Site (THR, TKR, Spine, Other Ortho) Infection Rates
NEBH SSI Rates 2003 – 2010 (outpatient and inpatient infections)
Conclusions: ,[object Object],[object Object],[object Object],[object Object]
Thank You

Mais conteúdo relacionado

Mais procurados

Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019Meningitis Research Foundation
 
Non-routine use of meningococcal vaccines in outbreaks and for individuals wi...
Non-routine use of meningococcal vaccines in outbreaks and for individuals wi...Non-routine use of meningococcal vaccines in outbreaks and for individuals wi...
Non-routine use of meningococcal vaccines in outbreaks and for individuals wi...Meningitis Research Foundation
 
Carriage studies - what do they add? Human bacterial challenge experiments as...
Carriage studies - what do they add? Human bacterial challenge experiments as...Carriage studies - what do they add? Human bacterial challenge experiments as...
Carriage studies - what do they add? Human bacterial challenge experiments as...Meningitis Research Foundation
 
Current issues with meningococcal vaccine programmes in the UK
Current issues with meningococcal vaccine programmes in the UKCurrent issues with meningococcal vaccine programmes in the UK
Current issues with meningococcal vaccine programmes in the UKMeningitis Research Foundation
 
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019Meningitis Research Foundation
 
Dr Sarah Meyer @ Meningitis & Septicaemia in Children & Adults
Dr Sarah Meyer @ Meningitis & Septicaemia in Children & AdultsDr Sarah Meyer @ Meningitis & Septicaemia in Children & Adults
Dr Sarah Meyer @ Meningitis & Septicaemia in Children & AdultsMeningitis Research Foundation
 
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017Meningitis Research Foundation
 
Dr Ado Bwaka @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Ado Bwaka @ MRF's Meningitis & Septicaemia in Children & Adults 2017Dr Ado Bwaka @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Ado Bwaka @ MRF's Meningitis & Septicaemia in Children & Adults 2017Meningitis Research Foundation
 
Human bacterial challenge experiments as an alternative
Human bacterial challenge experiments as an alternativeHuman bacterial challenge experiments as an alternative
Human bacterial challenge experiments as an alternativeMeningitis Research Foundation
 
Dr Joanne Langley @ MRF's Meningitis & Septicaemia in children and Adults 2017
Dr Joanne Langley @ MRF's Meningitis & Septicaemia in children and Adults 2017Dr Joanne Langley @ MRF's Meningitis & Septicaemia in children and Adults 2017
Dr Joanne Langley @ MRF's Meningitis & Septicaemia in children and Adults 2017Meningitis Research Foundation
 
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017Meningitis Research Foundation
 
Dr Adam Finn @ MRF's Meningitis & Septicaemia in children & Adults 2017
Dr Adam Finn @ MRF's Meningitis & Septicaemia in children & Adults 2017Dr Adam Finn @ MRF's Meningitis & Septicaemia in children & Adults 2017
Dr Adam Finn @ MRF's Meningitis & Septicaemia in children & Adults 2017Meningitis Research Foundation
 
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...Meningitis Research Foundation
 
Cupron medical textiles 2019
Cupron medical textiles 2019Cupron medical textiles 2019
Cupron medical textiles 2019JA Larson
 
The emerging picture of host genetic control of susceptibility and outcome in...
The emerging picture of host genetic control of susceptibility and outcome in...The emerging picture of host genetic control of susceptibility and outcome in...
The emerging picture of host genetic control of susceptibility and outcome in...Meningitis Research Foundation
 
Helen Campbell @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Helen Campbell @ MRF's Meningitis & Septicaemia in Children & Adults 2017Helen Campbell @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Helen Campbell @ MRF's Meningitis & Septicaemia in Children & Adults 2017Meningitis Research Foundation
 
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIVUC San Diego AntiViral Research Center
 

Mais procurados (20)

Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
Dr Kirsty Le Doare @ MRF's Meningitis and Septicaemia 2019
 
Non-routine use of meningococcal vaccines in outbreaks and for individuals wi...
Non-routine use of meningococcal vaccines in outbreaks and for individuals wi...Non-routine use of meningococcal vaccines in outbreaks and for individuals wi...
Non-routine use of meningococcal vaccines in outbreaks and for individuals wi...
 
Carriage studies - what do they add? Human bacterial challenge experiments as...
Carriage studies - what do they add? Human bacterial challenge experiments as...Carriage studies - what do they add? Human bacterial challenge experiments as...
Carriage studies - what do they add? Human bacterial challenge experiments as...
 
Current issues with meningococcal vaccine programmes in the UK
Current issues with meningococcal vaccine programmes in the UKCurrent issues with meningococcal vaccine programmes in the UK
Current issues with meningococcal vaccine programmes in the UK
 
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019
Dr Muhamed-Kheir Taha @ MRF's Meningitis and Septicaemia 2019
 
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
Dr Matt Coldiron @ MRF's Meningitis and SepticaemiaDr Matt Coldiron @ MRF's Meningitis and Septicaemia
Dr Matt Coldiron @ MRF's Meningitis and Septicaemia
 
Dr Sarah Meyer @ Meningitis & Septicaemia in Children & Adults
Dr Sarah Meyer @ Meningitis & Septicaemia in Children & AdultsDr Sarah Meyer @ Meningitis & Septicaemia in Children & Adults
Dr Sarah Meyer @ Meningitis & Septicaemia in Children & Adults
 
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
Prof Rick Malley @ Meningitis & Septicaemia in Children & Adults 2017
 
Dr Ado Bwaka @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Ado Bwaka @ MRF's Meningitis & Septicaemia in Children & Adults 2017Dr Ado Bwaka @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Ado Bwaka @ MRF's Meningitis & Septicaemia in Children & Adults 2017
 
Human bacterial challenge experiments as an alternative
Human bacterial challenge experiments as an alternativeHuman bacterial challenge experiments as an alternative
Human bacterial challenge experiments as an alternative
 
Dr Joanne Langley @ MRF's Meningitis & Septicaemia in children and Adults 2017
Dr Joanne Langley @ MRF's Meningitis & Septicaemia in children and Adults 2017Dr Joanne Langley @ MRF's Meningitis & Septicaemia in children and Adults 2017
Dr Joanne Langley @ MRF's Meningitis & Septicaemia in children and Adults 2017
 
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Dr Caroline Trotter @ MRF's Meningitis & Septicaemia in Children & Adults 2017
 
Dr Adam Finn @ MRF's Meningitis & Septicaemia in children & Adults 2017
Dr Adam Finn @ MRF's Meningitis & Septicaemia in children & Adults 2017Dr Adam Finn @ MRF's Meningitis & Septicaemia in children & Adults 2017
Dr Adam Finn @ MRF's Meningitis & Septicaemia in children & Adults 2017
 
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
 
Cupron medical textiles 2019
Cupron medical textiles 2019Cupron medical textiles 2019
Cupron medical textiles 2019
 
Dr Suzanne Anderson
Dr Suzanne AndersonDr Suzanne Anderson
Dr Suzanne Anderson
 
The emerging picture of host genetic control of susceptibility and outcome in...
The emerging picture of host genetic control of susceptibility and outcome in...The emerging picture of host genetic control of susceptibility and outcome in...
The emerging picture of host genetic control of susceptibility and outcome in...
 
Helen Campbell @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Helen Campbell @ MRF's Meningitis & Septicaemia in Children & Adults 2017Helen Campbell @ MRF's Meningitis & Septicaemia in Children & Adults 2017
Helen Campbell @ MRF's Meningitis & Septicaemia in Children & Adults 2017
 
Dr Kirsty Le Doare @ MRF's Meningitis & Septicaemia
Dr Kirsty Le Doare @ MRF's Meningitis & Septicaemia Dr Kirsty Le Doare @ MRF's Meningitis & Septicaemia
Dr Kirsty Le Doare @ MRF's Meningitis & Septicaemia
 
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
 

Semelhante a Mrsa eradication presentation sep 30 2010

Periop conference working toward zero ssi - sep 11 2010
Periop conference   working toward zero ssi - sep 11 2010Periop conference   working toward zero ssi - sep 11 2010
Periop conference working toward zero ssi - sep 11 2010Maureen Spencer, RN, M.Ed.
 
Prevention mrsa.ppt.shirlhooper
Prevention mrsa.ppt.shirlhooperPrevention mrsa.ppt.shirlhooper
Prevention mrsa.ppt.shirlhooperShirl Hooper
 
Role of the Laboratory in Antimicrobial Resistance Data
Role of the Laboratory in Antimicrobial Resistance DataRole of the Laboratory in Antimicrobial Resistance Data
Role of the Laboratory in Antimicrobial Resistance DataAnuj Sharma
 
MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015NHS England
 
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemTackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemViewics
 
CLINICAL AUDIT: ADHERENCE TO ANTIBIOTIC PROPHYLAXIS FOR CHEMOPORT INSERTION G...
CLINICAL AUDIT: ADHERENCE TO ANTIBIOTIC PROPHYLAXIS FOR CHEMOPORT INSERTION G...CLINICAL AUDIT: ADHERENCE TO ANTIBIOTIC PROPHYLAXIS FOR CHEMOPORT INSERTION G...
CLINICAL AUDIT: ADHERENCE TO ANTIBIOTIC PROPHYLAXIS FOR CHEMOPORT INSERTION G...Pharmacy @ Institut Kanser Negara
 
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...Eastern Pennsylvania Branch ASM
 
Fresh from the press: Updated best practices in Surgical Site Infection Preve...
Fresh from the press: Updated best practices in Surgical Site Infection Preve...Fresh from the press: Updated best practices in Surgical Site Infection Preve...
Fresh from the press: Updated best practices in Surgical Site Infection Preve...Canadian Patient Safety Institute
 
EFFECTS OF MRSA SCREENING ON THE HEALTH.docx
EFFECTS OF MRSA SCREENING ON THE HEALTH.docxEFFECTS OF MRSA SCREENING ON THE HEALTH.docx
EFFECTS OF MRSA SCREENING ON THE HEALTH.docxwrite5
 
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docxsodhi3
 
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docxblondellchancy
 
JBry The Difference Between Physician Lit Review
JBry The Difference Between Physician Lit ReviewJBry The Difference Between Physician Lit Review
JBry The Difference Between Physician Lit ReviewJessica Bryan
 
COVID RAPID RESULT SERUM TESTING
COVID RAPID RESULT SERUM TESTINGCOVID RAPID RESULT SERUM TESTING
COVID RAPID RESULT SERUM TESTINGScott Hashisaki
 
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...iosrphr_editor
 
Pharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSAPharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSAStevce Acevski
 

Semelhante a Mrsa eradication presentation sep 30 2010 (20)

Periop conference working toward zero ssi - sep 11 2010
Periop conference   working toward zero ssi - sep 11 2010Periop conference   working toward zero ssi - sep 11 2010
Periop conference working toward zero ssi - sep 11 2010
 
Orthopedic residents orientation july 2010
Orthopedic residents orientation july 2010Orthopedic residents orientation july 2010
Orthopedic residents orientation july 2010
 
Prevention mrsa.ppt.shirlhooper
Prevention mrsa.ppt.shirlhooperPrevention mrsa.ppt.shirlhooper
Prevention mrsa.ppt.shirlhooper
 
Role of the Laboratory in Antimicrobial Resistance Data
Role of the Laboratory in Antimicrobial Resistance DataRole of the Laboratory in Antimicrobial Resistance Data
Role of the Laboratory in Antimicrobial Resistance Data
 
MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015
 
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management ProblemTackling the U.S. Healthcare System’s Infectious Disease Management Problem
Tackling the U.S. Healthcare System’s Infectious Disease Management Problem
 
ICAAC 2015 Selection
ICAAC 2015 SelectionICAAC 2015 Selection
ICAAC 2015 Selection
 
Prevalence of mrsa
Prevalence of mrsaPrevalence of mrsa
Prevalence of mrsa
 
Int j healthalliedsci_2016_5_4_210_194083
Int j healthalliedsci_2016_5_4_210_194083Int j healthalliedsci_2016_5_4_210_194083
Int j healthalliedsci_2016_5_4_210_194083
 
CLINICAL AUDIT: ADHERENCE TO ANTIBIOTIC PROPHYLAXIS FOR CHEMOPORT INSERTION G...
CLINICAL AUDIT: ADHERENCE TO ANTIBIOTIC PROPHYLAXIS FOR CHEMOPORT INSERTION G...CLINICAL AUDIT: ADHERENCE TO ANTIBIOTIC PROPHYLAXIS FOR CHEMOPORT INSERTION G...
CLINICAL AUDIT: ADHERENCE TO ANTIBIOTIC PROPHYLAXIS FOR CHEMOPORT INSERTION G...
 
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...
MRSA Screening-Non molecular vs molecular testing - Dr Gerri Hall - November ...
 
Fresh from the press: Updated best practices in Surgical Site Infection Preve...
Fresh from the press: Updated best practices in Surgical Site Infection Preve...Fresh from the press: Updated best practices in Surgical Site Infection Preve...
Fresh from the press: Updated best practices in Surgical Site Infection Preve...
 
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY (Overcoming with Newer Approac...
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY(Overcoming with Newer Approac...EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY(Overcoming with Newer Approac...
EMERGING CHALLENGES IN DIAGNOSTIC MICROBIOLOGY (Overcoming with Newer Approac...
 
EFFECTS OF MRSA SCREENING ON THE HEALTH.docx
EFFECTS OF MRSA SCREENING ON THE HEALTH.docxEFFECTS OF MRSA SCREENING ON THE HEALTH.docx
EFFECTS OF MRSA SCREENING ON THE HEALTH.docx
 
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx
 
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx
8Catheter-Associated Urinary Tract Infections (CAUTI)Walden .docx
 
JBry The Difference Between Physician Lit Review
JBry The Difference Between Physician Lit ReviewJBry The Difference Between Physician Lit Review
JBry The Difference Between Physician Lit Review
 
COVID RAPID RESULT SERUM TESTING
COVID RAPID RESULT SERUM TESTINGCOVID RAPID RESULT SERUM TESTING
COVID RAPID RESULT SERUM TESTING
 
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
IOSR Journal of Pharmacy (IOSRPHR), www.iosrphr.org, call for paper, research...
 
Pharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSAPharmacoeconomic aspects for treatment of MRSA
Pharmacoeconomic aspects for treatment of MRSA
 

Mais de Maureen Spencer, RN, M.Ed.

Periop conference clostridium difficile sep 11 2010
Periop conference   clostridium difficile sep 11 2010Periop conference   clostridium difficile sep 11 2010
Periop conference clostridium difficile sep 11 2010Maureen Spencer, RN, M.Ed.
 
Infection control and energy medicine 092108 new york city
Infection control and energy medicine 092108    new york cityInfection control and energy medicine 092108    new york city
Infection control and energy medicine 092108 new york cityMaureen Spencer, RN, M.Ed.
 
Creative hand hygiene programs to motivate staff oct 19 2010
Creative hand hygiene programs to motivate staff oct 19 2010Creative hand hygiene programs to motivate staff oct 19 2010
Creative hand hygiene programs to motivate staff oct 19 2010Maureen Spencer, RN, M.Ed.
 

Mais de Maureen Spencer, RN, M.Ed. (17)

Establishing a culture of safety april 2012
Establishing a culture of safety   april 2012Establishing a culture of safety   april 2012
Establishing a culture of safety april 2012
 
Periop conference mrsa and mssa - sep 11 2010
Periop conference   mrsa and mssa - sep 11 2010Periop conference   mrsa and mssa - sep 11 2010
Periop conference mrsa and mssa - sep 11 2010
 
Periop conference clostridium difficile sep 11 2010
Periop conference   clostridium difficile sep 11 2010Periop conference   clostridium difficile sep 11 2010
Periop conference clostridium difficile sep 11 2010
 
Mrsa and mssa mna nov 12 2010
Mrsa and mssa   mna nov 12 2010Mrsa and mssa   mna nov 12 2010
Mrsa and mssa mna nov 12 2010
 
Infection control and energy medicine 092108 new york city
Infection control and energy medicine 092108    new york cityInfection control and energy medicine 092108    new york city
Infection control and energy medicine 092108 new york city
 
Evidence based hygiene strategies 102308
Evidence based hygiene strategies 102308Evidence based hygiene strategies 102308
Evidence based hygiene strategies 102308
 
Creative hand hygiene programs to motivate staff oct 19 2010
Creative hand hygiene programs to motivate staff oct 19 2010Creative hand hygiene programs to motivate staff oct 19 2010
Creative hand hygiene programs to motivate staff oct 19 2010
 
Clostridium difficile 2010
Clostridium difficile 2010Clostridium difficile 2010
Clostridium difficile 2010
 
Toronto ethicon lecture jan 2010
Toronto ethicon lecture   jan 2010Toronto ethicon lecture   jan 2010
Toronto ethicon lecture jan 2010
 
Mha using measurement to inform and improve
Mha using measurement to inform and improveMha using measurement to inform and improve
Mha using measurement to inform and improve
 
New precaution manual new version june 2010
New precaution manual   new version june 2010New precaution manual   new version june 2010
New precaution manual new version june 2010
 
Yoga in america free download book
Yoga in america free download bookYoga in america free download book
Yoga in america free download book
 
Chakra system slide presentation
Chakra system  slide presentationChakra system  slide presentation
Chakra system slide presentation
 
Yoga and meditation lecture
Yoga and meditation lectureYoga and meditation lecture
Yoga and meditation lecture
 
Anatomy and physiology1
Anatomy and physiology1Anatomy and physiology1
Anatomy and physiology1
 
Ayurveda and asana
Ayurveda and asanaAyurveda and asana
Ayurveda and asana
 
Yoga for diabetes and obesity 2010
Yoga for diabetes and obesity 2010Yoga for diabetes and obesity 2010
Yoga for diabetes and obesity 2010
 

Mrsa eradication presentation sep 30 2010

Notas do Editor

  1. And this will continue to increase due to the older population and more active lifestyles, the emergence of new less invasive procedures and newer technology.
  2. 17 MSSA isolates and 10 MRSA isolates were sent to the Mayo Clinic for pulsed field gel electrophoresis to determine if we were experiencing a point source outlbreak. None of the strains had the same number and size of bands to indicate a point source outbreak or carrier among staff.
  3. We conducted another anonymous surveillance culture study in Feb 2006 – 133 spine patients noses were cultured in the OR 29% grew out Staph aureus and 4% were positive for MRSA – which was undiagnosed and therefore surgical prophylaxis with Vancomycin was not administered and no precautions were used in the OR, PACU or nursing units. These patients may also Have been discharged to a rehab facility with no flagging for precautions.
  4. Surveillance is the systematic collection of identified patient outcomes. The National Nosocomial Infection Surveillance data collected By the Centers for Disease control from approx 250 US hospitals is used for benchmarking infection rates. The key to infection control surveillance Data in a hospital is that the information be collected using standardized definitions, analyzed using sound epidemiologic principles and Used within the healthcare facility. Communication is key!